International pharmaceutical conglomerate GSK, or GlaxoSmithKline, has begun the process of reviewing its global media planning and buying business. Australian trade publication AdNews broke the news yesterday, and today a company representative confirmed the review to Adweek but did not provide additional information.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in